Atlas Trials

First-time Usage of SGLT2 Inhibitors in Type 2 Diabetic Patients Who Are Fasting During Ramadan: Safety and Efficacy

Clinical trial NCT06370247 · COMPLETED

Trial details

NCT number
NCT06370247
Sponsor
Sohag University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
SGLT2 Inhibitors, First Time UseType2 DiabetesFasting in Ramadan
Start date
2023-04-25
Primary completion
2023-06-25
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.